The Board of Directors of Bayer CropScience is scheduled to meet on November 7, 2025, to consider, among other items, the unaudited financial results for the quarter ended September 30, 2025. Also on the agenda is the consideration of an interim dividend for the financial year 2025-26, and the setting of a record date for dividend eligibility. The company has closed its trading window per insider trading regulations.
Board Meeting Announcement
A meeting of the Board of Directors is scheduled for November 7, 2025. During this meeting, the board will review and discuss several key items related to the company’s performance and strategic direction.
Financial Results and Dividend
The primary focus of the meeting will be the review and approval of the unaudited financial results for the second quarter of fiscal year 2025 (quarter ended September 30, 2025). Furthermore, the Board will deliberate on the declaration of an interim dividend for the financial year 2025-26. If approved, the board will also set a record date to determine shareholders’ eligibility for the dividend payout.
Trading Window Closure
In compliance with insider trading regulations, the company has already closed its trading window for designated persons. This measure ensures fair and transparent trading practices during the sensitive period leading up to the board meeting and the announcement of financial results and dividend decisions.
Source: BSE
